22nd Jul 2020 20:43
Physiomics PLC - oncology consultant - Says no specific reason for recent rise in share price. Notes it is still in the late stages of finalising a contract with a "new large pharmaceutical client".
Current stock price: 10.44 pence
Year-to-date change: more than trebled from 3.45p
By Eric Cunha; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Physiomics